Evaluation of the prognostic significance of BCL6 gene expression in canine high-grade B-cell lymphoma

Veterinary Journal

Volumn 191, Issue 1, 2012, Pages 108-114

  Sato, Masahiko ^a   Kanemoto, Hideyuki ^a   Kagawa, Yumiko ^b   Kobayashi, Tetsuya ^c   Goto Koshino, Yuko ^a   Mochizuki, Hiroyuki ^a   Takahashi, Masashi ^a   Fujino, Yasuhito ^a   Ohno, Koichi ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b North Lab   (Japan)

^c Japan Small Animal Cancer Center   (Japan)

Author keywords

BCL6; Diffuse large B cell lymphoma; Dog; Lymphoma; Oncology

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MESSENGER RNA; PREDNISOLONE; VINCRISTINE;

ANIMAL TISSUE; ARTICLE; ASPIRATION BIOPSY; B CELL LYMPHOMA; BCL6 GENE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DOG; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-6; RNA, MESSENGER;

CANIS FAMILIARIS;

EID: 84855533804     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.12.006     Document Type: Article

References (37)

1. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
2. Alvarez F.J., Kisseberth W.C., Gallant S.L., Couto C.G. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma. Journal of Veterinary Internal Medicine 2006, 20:1178-1183.
3. Burnett R.C., Vernau W., Modiano J.F., Olver C.S., Moore P.F., Avery A.C. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Veterinary Pathology 2003, 40:32-41.
4. Chang C.C., Ye B.H., Chaganti R.S., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:6947-6952.
5. Coiffier B. Diffuse large cell lymphoma. Current Opinion in Oncology 2001, 13:325-334.
6. Deweindt C., Albagli O., Bernardin F., Dhordain P., Quief S., Lantoine D., Kerckaert J.P., Leprince D. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth and Differentiation 1995, 6:1495-1503.
7. Fournel-Fleury C., Magnol J.P., Bricaire P., Marchal T., Chabanne L., Delverdier A., Bryon P.A., Felman P. Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. Journal of Comparative Pathology 1997, 117:35-59.
8. Garrett L.D., Thamm D.H., Chun R., Dudley R., Vail D.M. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. Journal of Veterinary Internal Medicine 2002, 16:704-709.
9. Greenlee P.G., Filippa D.A., Quimby F.W., Patnaik A.K., Calvano S.E., Matus R.E., Kimmel M., Hurvitz A.I., Lieberman P.H. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990, 66:480-490.
10. Griessmayr P.C., Payne S.E., Winter J.E., Barber L.G., Shofer F.S. Dacarbazine as single-agent therapy for relapsed lymphoma in dogs. Journal of Veterinary Internal Medicine 2009, 23:1227-1231.
11. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., Muller-Hermelink H.K., Campo E., Braziel R.M., Jaffe E.S., Pan Z., Farinha P., Smith L.M., Falini B., Banham A.H., Rosenwald A., Staudt L.M., Connors J.M., Armitage J.O., Chan W.C. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-282.
12. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994, 84:1361-1392.
13. Hosoya K., Kisseberth W.C., Lord L.K., Alvarez F.J., Lara-Garcia A., Kosarek C.E., London C.A., Couto C.G. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine 2007, 21:1355-1363.
14. Jacobs R.M., Messick J.B., Valli V.E. Tumors of the hemolymphatic system. Tumors of Domestic Animals 2002, 138. State Press, Iowa. fourth ed. D.J. Meuten (Ed.).
15. Jaffe E.S. Histopathology of the non-Hodgkin's lymphomas and Hodgkin's disease. The Lymphomas 1998, 77-106. WB Saunders, Philadelphia, PA, USA. G.P. Canellos, T.A. Listrer, J.L. Sklar (Eds.).
16. Jamadar-Shroff V., Papich M.G., Suter S.E. Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines. Clinical Cancer Research 2009, 15:1269-1276.
17. Kaiser H.E. Animal neoplasms: a systemic review. Neoplasms - Comparative Pathology in Animals, Plants and Man 1981, 747-812. Williams and Wilkins Baltimore, MD. H.E. Kaiser (Ed.).
18. Lossos I.S., Jones C.D., Warnke R., Natkunam Y., Kaizer H., Zehnder J.L., Tibshirani R., Levy R. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001, 98:945-951.
19. MacEwen E.G., Hayes A.A., Matus R.E., Kurzman I. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). Journal of the American Veterinary Medical Association 1987, 190:564-568.
20. Miller A.G., Morley P.S., Rao S., Avery A.C., Lana S.E., Olver C.S. Anemia is associated with decreased survival time in dogs with lymphoma. Journal of Veterinary Internal Medicine 2009, 23:116-122.
21. Perez-Rosado A., Artiga M., Vargiu P., Sanchez-Aguilera A., Alvarez-Barrientos A., Piris M. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. Journal of Pathology 2008, 214:498-507.
22. Peters I.R., Peeters D., Helps C.R., Day M.J. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Veterinary Immunology and Immunopathology 2007, 117:55-66.
23. Ponce F., Marchal T., Magnol J.P., Turinelli V., Ledieu D., Bonnefont C., Pastor M., Delignette M.L., Fournel-Fleury C. A morphologic study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Veterinary Pathology 2010, 47:414-433.
24. Reljic R., Wagner S.D., Peakman L.J., Fearon D.T. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. Journal of Experimental Medicine 2000, 192:1841-1848.
25. Saba C.F., Thamm D.H., Vail D.M. Combination chemotherapy with l-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. Journal of Veterinary Internal Medicine 2007, 21:127-132.
26. Sato, M., Goto-Koshino, Y., Kanemoto, H., Mochizuki, H., Fujino, Y., Ohno, K., Tsujimoto, H., in press. Characterization of canine BCL6 cDNA and detection systems for its protein expression. Veterinary Immunology and Immunopathology.
27. Schebesta M., Heavey B., Busslinger M. Transcriptional control of B-cell development. Current Opinion in Immunology 2002, 14:216-223.
28. Seyfert V.L., Allman D., He Y., Staudt L.M. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 1996, 12:2331-2342.
29. Tamura K., Yagihara H., Isotani M., Ono K., Washizu T., Bonkobara M. Development of the polymerase chain reaction assay based on the canine genome database for detection of monoclonality in B cell lymphoma. Veterinary Immunology and Immunopathology 2006, 110:163-167.
30. Uccella S., Placidi C., Marchet S., Cergnul M., Proserpio I., Chini C., Novario R., Pinotti G., Capella C. Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: a single centre experience. Leukemia and Lymphoma 2008, 49:1321-1328.
31. Uppenkamp M., Feller A.C. Classification of malignant lymphoma. Onkologie 2002, 25:563-570.
32. Vail D.M., Thamm D.H., Reiser H., Ray A.S., Wolfgang G.H., Watkins W.J., Babusis D., Henne I.N., Hawkins M.J., Kurzman I.D., Jeraj R., Vanderhoek M., Plaza S., Anderson C., Wessel M.A., Robat C., Lawrence J., Tumas D.B. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clinical Cancer Research 2009, 15:3503-3510.
33. Vail D.M., Michels G.M., Khanna C., Selting K.A., London C.A. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0) - a veterinary cooperative oncology group (VCOG) consensus document. Veterinary and Comparative Oncology 2010, 8:28-37.
34. Valli, V.E., Jacobs, R.M., Parodi, A.L., Vernau, W., Moore, P.F., 2002. Histological Classification of Hematopoietic Tumors of Domestic Animals. World Health Organization International Histological Classification of Tumors of Domestic Animals, Second Series, vol. VIII. Armed Forces Institute of Pathology, Washington, DC, pp. 35-38.
35. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3. (RESEARCH0034).
36. Vezzali E., Parodi A.L., Marcato P.S., Bettini G. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Veterinary and Comparative Oncology 2010, 8:38-49.
37. Yamazaki J., Baba K., Goto-Koshino Y., Setoguchi-Mukai A., Fujino Y., Ohno K., Tsujimoto H. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction. Veterinary Immunology and Immunopathology 2008, 126:321-331.